NK cell inflammation in the clinical outcome of colorectal carcinoma

Frontiers in Medicine

Volumn 2, Issue MAY, 2015, Pages

  Coppola, Andrea ^a   Arriga, Roberto ^a   Lauro, Davide ^a   del Principe, Maria Ilaria ^a   Buccisano, Francesco ^a   Maurillo, Luca ^a   Palomba, Patrizia ^a   Venditti, Adriano ^a   Sconocchia, Giuseppe ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

CD8 + T cells; Colorectal carcinoma; Cooperation; Inflammation; NK cells; Survival

Indexed keywords

EID: 84947570829     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2015.00033     Document Type: Short Survey

References (32)

1. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol (1986) 136:4480-6
2. Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med (1986) 164:814-25. doi: 10.1084/jem.164.3.814
3. Sconocchia G, Keyvanfar K, El OF, Grube M, Rezvani K, Fujiwara H, et al. Phenotype and function of a CD56+ peripheral blood monocyte. Leukemia (2005) 19:69-76. doi:10.1038/sj.leu.2403550
4. Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 87:2632-40
5. Sconocchia G, Provenzano M, Rezvani K, Li J, Melenhorst J, Hensel N, et al. CD34+ cells cultured in stem cell factor and interleukin-2 generate CD56+ cells with antiproliferative effects on tumor cell lines. J Transl Med (2005) 3:15. doi:10.1186/1479-5876-3-15
6. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 19:197-223. doi:10.1146/annurev.immunol.19.1.197
7. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A (1999) 96:5640-4. doi:10.1073/pnas.96.10.5640
8. Moretta L, Pietra G, Montaldo E, Vacca P, Pende D, Falco M, et al. Human NK cells: from surface receptors to the therapy of leukemias and solid tumors. Front Immunol (2014) 5:87. doi:10.3389/fimmu.2014.00087
9. Lanier LL. Turning on natural killer cells. J Exp Med (2000) 191:1259-62. doi:10.1084/jem.191.8.1259
10. Sconocchia G, Titus JA, Mazzoni A, Visintin A, Pericle F, Hicks SW, et al. CD38 triggers cytotoxic responses in activated human natural killer cells. Blood (1999) 94:3864-71
11. Thielens A, Vivier E, Romagne F. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol (2012) 24:239-45. doi:10.1016/j.coi.2012.01.001
12. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res (2007) 13:1472-9. doi:10.1158/1078-0432.CCR-06-2073
13. Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, et al. Colorectal cancer infiltration by myeloperoxidase positive neutrophil granulocytes is associated with favorable prognosis. Oncoimmunology (2013) 2:e25990. doi:10.4161/onci.25990
14. Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, et al. Tumor infiltration by FcgammaRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer (2011) 128:2663-72. doi:10.1002/ijc.25609
15. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 353:2654-66. doi:10.1056/NEJMoa051424
16. Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer (2010) 126:2635-43. doi:10.1002/ijc.24989
17. Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, et al. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One (2012) 7:e47045. doi:10.1371/journal.pone.0047045
18. Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions-letter. Cancer Res (2012) 72:5428-9. doi:10.1158/0008-5472.CAN-12-1181
19. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer (1997) 79: 2320-8. doi:10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P
20. Peng YP, Zhu Y, Zhang JJ, Xu ZK, Qian ZY, Dai CC, et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Transl Med (2013) 11:262. doi:10.1186/1479-5876-11-262
21. Desbois M, Rusakiewicz S, Locher C, Zitvogel L, Chaput N. Natural killer cells in non-hematopoietic malignancies. Front Immunol (2012) 3:395. doi:10.3389/fimmu.2012.00395
22. Sconocchia G, Eppenberger-Castori S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, et al. NK cells and T cells cooperate during the clinical course of colorectal cancer. Oncoimmunology (2014) 3:e952197. doi:10.4161/21624011.2014.952197
23. Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res (2012) 72:1407-15. doi:10.1158/0008-5472.CAN-11-2544
24. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest (2011) 121:3609-22. doi:10.1172/JCI45816
25. Sconocchia G, Spagnoli GC, Del PD, Ferrone S, Anselmi M, Wongsena W, et al. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia (2009) 11:662-71. doi:10.1593/neo.09296
26. Sconocchia G, Arriga R, Caratelli S, Basello K, Coppola A, Capuani B, et al. Leukemia and epithelial cancer cells trigger NK cell storming: the NK cell alloperturbation phenomenon. Bone Marrow Transplant (2011) 46:S325.a
27. Grzywacz B, Kataria N, Verneris MR. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia (2007) 21:356-9. doi:10.1038/sj.leu.2404499
28. Jewett A, Cavalcanti M, Bonavida B. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol (1997) 159:4815-22
29. Cottone L, Capobianco A, Gualteroni C, Perrotta C, Bianchi ME, Rovere-Querini P, et al. 5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells. Int J Cancer (2015) 136:1381-9. doi:10.1002/ijc.29125
30. Coppola A, Caputo MP, Capuani B, Pastore D, Pacifici F, Arriga R, et al. IL-2 activated natural killer cells release leptin after high mobility group box-1 stimulation. Diabetes (2014) 63(Suppl 1):A75
31. Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, et al. HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker. Neoplasia (2014) 16:31-42
32. Lorre K, Kasran A, Van VF, de BM, Ceuppens JL. Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells. Clin Immunol Immunopathol (1994) 70:81-90. doi:10.1006/clin.1994.1014